Correction to: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial (Nature Medicine, (2023), 29, 7, (1782-1792), 10.1038/s41591-023-02427-z)

Deepak L. Bhatt; Harold E. Bays; Michael Miller; James E. Cain; Katarzyna Wasilewska; Nabil S. Andrawis; Teresa Parli; Shibao Feng; Lulu Sterling; Leo Tseng; Cynthia L. Hartsfield; Germaine D. Agollah; Hank Mansbach; ENTRIGUE Principal Investigators

doi:10.1038/s41591-024-02890-2

Correction to: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial (Nature Medicine, (2023), 29, 7, (1782-1792), 10.1038/s41591-023-02427-z)

Deepak L. Bhatt, Harold E. Bays, Michael Miller, James E. Cain, Katarzyna Wasilewska, Nabil S. Andrawis, Teresa Parli, Shibao Feng, Lulu Sterling, Leo Tseng, Cynthia L. Hartsfield, Germaine D. Agollah, Hank Mansbach, ENTRIGUE Principal Investigators

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02427-z, published online 24 June 2023. In the version of the article initially published, there were errors in Fig. 3d. The panel has now been corrected in the HTML and PDF versions of the article, and the original and revised versions can be seen below as Fig. 1. (Figure presented.) Original and revised Fig. 3d.

Original language	English
Pages (from-to)	1788-1789
Number of pages	2
Journal	Nature medicine
Volume	30
Issue number	6
Early online date	2024
DOIs	https://doi.org/10.1038/s41591-024-02890-2
Publication status	Published - Jun 2024

Access to Document

10.1038/s41591-024-02890-2

Cite this

Bhatt, D. L., Bays, H. E., Miller, M., Cain, J. E., Wasilewska, K., Andrawis, N. S., Parli, T., Feng, S., Sterling, L., Tseng, L., Hartsfield, C. L., Agollah, G. D., Mansbach, H., & ENTRIGUE Principal Investigators (2024). Correction to: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial (Nature Medicine, (2023), 29, 7, (1782-1792), 10.1038/s41591-023-02427-z). Nature medicine, 30(6), 1788-1789. https://doi.org/10.1038/s41591-024-02890-2

@article{9d8621dcf8c744ddb05bff6503ea759f,

title = "Correction to: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial (Nature Medicine, (2023), 29, 7, (1782-1792), 10.1038/s41591-023-02427-z)",

abstract = "Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02427-z, published online 24 June 2023. In the version of the article initially published, there were errors in Fig. 3d. The panel has now been corrected in the HTML and PDF versions of the article, and the original and revised versions can be seen below as Fig. 1. (Figure presented.) Original and revised Fig. 3d.",

author = "Bhatt, {Deepak L.} and Bays, {Harold E.} and Michael Miller and Cain, {James E.} and Katarzyna Wasilewska and Andrawis, {Nabil S.} and Teresa Parli and Shibao Feng and Lulu Sterling and Leo Tseng and Hartsfield, {Cynthia L.} and Agollah, {Germaine D.} and Hank Mansbach and {ENTRIGUE Principal Investigators} and Kastelein, {John J. P.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = jun,

doi = "10.1038/s41591-024-02890-2",

language = "English",

volume = "30",

pages = "1788--1789",

journal = "Nature medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

number = "6",

}

Bhatt, DL, Bays, HE, Miller, M, Cain, JE, Wasilewska, K, Andrawis, NS, Parli, T, Feng, S, Sterling, L, Tseng, L, Hartsfield, CL, Agollah, GD, Mansbach, H & ENTRIGUE Principal Investigators 2024, 'Correction to: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial (Nature Medicine, (2023), 29, 7, (1782-1792), 10.1038/s41591-023-02427-z)', Nature medicine, vol. 30, no. 6, pp. 1788-1789. https://doi.org/10.1038/s41591-024-02890-2

Correction to: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial (Nature Medicine, (2023), 29, 7, (1782-1792), 10.1038/s41591-023-02427-z). / Bhatt, Deepak L.; Bays, Harold E.; Miller, Michael et al.
In: Nature medicine, Vol. 30, No. 6, 06.2024, p. 1788-1789.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Correction to

T2 - The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial (Nature Medicine, (2023), 29, 7, (1782-1792), 10.1038/s41591-023-02427-z)

AU - Bhatt, Deepak L.

AU - Bays, Harold E.

AU - Miller, Michael

AU - Cain, James E.

AU - Wasilewska, Katarzyna

AU - Andrawis, Nabil S.

AU - Parli, Teresa

AU - Feng, Shibao

AU - Sterling, Lulu

AU - Tseng, Leo

AU - Hartsfield, Cynthia L.

AU - Agollah, Germaine D.

AU - Mansbach, Hank

AU - ENTRIGUE Principal Investigators

AU - Kastelein, John J. P.

PY - 2024/6

Y1 - 2024/6

N2 - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02427-z, published online 24 June 2023. In the version of the article initially published, there were errors in Fig. 3d. The panel has now been corrected in the HTML and PDF versions of the article, and the original and revised versions can be seen below as Fig. 1. (Figure presented.) Original and revised Fig. 3d.

AB - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02427-z, published online 24 June 2023. In the version of the article initially published, there were errors in Fig. 3d. The panel has now been corrected in the HTML and PDF versions of the article, and the original and revised versions can be seen below as Fig. 1. (Figure presented.) Original and revised Fig. 3d.

UR - http://www.scopus.com/inward/record.url?scp=85186581240&partnerID=8YFLogxK

U2 - 10.1038/s41591-024-02890-2

DO - 10.1038/s41591-024-02890-2

M3 - Comment/Letter to the editor

C2 - 38438737

SN - 1078-8956

VL - 30

SP - 1788

EP - 1789

JO - Nature medicine

JF - Nature medicine

IS - 6

ER -

Correction to: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial (Nature Medicine, (2023), 29, 7, (1782-1792), 10.1038/s41591-023-02427-z)

Abstract

Access to Document

Other files and links

Cite this